River Street Advisors LLC Bristol Myers Squibb CO Transaction History

River Street Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	SELL	$48.48 - $57.85 $96,087 - $114,658	-1,982 Reduced 16.95%	9,714 $498 Million
Q3 2023 Oct 26, 2023	BUY	$57.89 - $64.73 $30,450 - $34,047	526 Added 4.71%	11,696 $679 Million
Q2 2023 Jul 21, 2023	SELL	$63.71 - $70.74 $16,246 - $18,038	-255 Reduced 2.23%	11,170 $714 Million
Q1 2023 May 03, 2023	BUY	$65.71 - $74.53 $18,135 - $20,570	276 Added 2.48%	11,425 $792 Million
Q4 2022 Feb 08, 2023	BUY	$68.48 - $81.09 $763,483 - $904,072	11,149 New	11,149 $802 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of River Street Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on River Street Advisors LLC with notifications on news.